Table I. Selection analyses of snake venom metalloproteinase (SVMP) propeptides. ω: mean dN/dS.
SLACa | FELb | RELc | Integrative analyses | MEMEd | PAMLg | ||
---|---|---|---|---|---|---|---|
SLAC + FEL + REL + MEME | M8 | M2a | |||||
Psammophis | |||||||
ω > 1e | 0 | 1 | 0 | 2 | 2 | 1 | |
Monodomain | |||||||
ω < 1f | 1 | 2 | 4 | 4 | 1 | (0 + 2) | (0 + 1) |
SVMP | |||||||
ω = | 0.95 | - | 2.51 | - | 1.23 | 1.24 | |
Echis | |||||||
ω > 1e | 0 | 0 | 2 | 2 | 0 | 0 | |
Monodomain | |||||||
ω < 1f | 0 | 4 | 1 | 5 | 0 | ||
SVMP | |||||||
ω = | 0.32 | - | 0.43 | - | 0.52 | 0.52 | |
Echis | |||||||
ω > 1e | 0 | 1 | 2 | 3 | 0 | 0 | |
Multidomain | |||||||
ω < 1f | 5 | 12 | 0 | 12 | 1 | ||
SVMP | |||||||
ω = | 0.47 | - | 0.82 | - | 0.46 | 0.46 |
a Single Likelihood Ancestor Counting.
b Fixed-effects likelihood.
c Random-effects likelihood.
d Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed Effects Model Evolution (MEME).
e Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for REL).
f Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for REL).
g Positively selected sites detected using the Bayes Empirical Bayes approach implemented in the site models (M8 and M2a). Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis.